Maverick Capital’s Eastman Chemical EMN Stock Holding History

Maverick Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,614	Closed	-$414K	–	452
2023 Q4	$414K	Buy	+4,614	New	+$368K	0.01%	224
2021 Q4	–	Sell	-5,786	Closed	-$583K	–	418
2021 Q3	$583K	Buy	+5,786	New	+$638K	0.01%	421
2021 Q1	–	Sell	-2,964	Closed	-$297K	–	758
2020 Q4	$297K	Sell	2,964 -7,831	-73%	-$726K	﹤0.01%	453
2020 Q3	$843K	Sell	10,795 -38,693	-78%	-$2.92M	0.02%	323
2020 Q2	$3.45M	Buy	49,488 +29,705	+150%	+$1.87M	0.07%	82
2020 Q1	$921K	Sell	19,783 -6,743	-25%	-$433K	0.02%	323
2019 Q4	$2.1M	Buy	+26,526	New	+$2.04M	0.03%	257
2019 Q3	–	Sell	-2,020	Closed	-$157K	–	353
2019 Q2	$157K	Buy	+2,020	New	+$153K	﹤0.01%	277
2018 Q3	–	Sell	-53,750	Closed	-$5.37M	–	252
2018 Q2	$5.37M	Buy	+53,750	New	+$5.67M	0.06%	173

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Maverick Capital's EMN Position: Q1 2024 in Review

Maverick Capital sold out of Eastman Chemical (EMN) in Q1 2024, closing a stake of 4,614 shares — an estimated $414K sold.

Maverick Capital first reported a position in EMN in Q2 2018 and held it in 9 quarters. The position peaked at $5.37M in Q2 2018. 748 funds tracked by Wall St. Rank hold EMN as of Q1 2024.

Maverick Capital reported no remaining Eastman Chemical position as of Q1 2024 after selling out during the quarter.
Maverick Capital sold 4,614 Eastman Chemical shares in Q1 2024, an estimated $414K.
Maverick Capital first reported a position in Eastman Chemical in Q2 2018 and held it in 9 quarters.
Maverick Capital's Eastman Chemical position peaked at $5.37M in Q2 2018.
748 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2024.

Based on Maverick Capital's 13F filing for Q1 2024, filed 15 May 2024.